Total Payments
$869.45
2023 Payments
$47.14
Companies
16
Transactions
49
Medicare Patients
7,929
Medicare Billing
$836,385
Payment Breakdown by Category
Food & Beverage$774.50 (89.1%)
Education$94.95 (10.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $774.50 | 44 | 89.1% |
| Education | $94.95 | 5 | 10.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| STRATA Skin Sciences, Inc. | $226.42 | 13 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $164.86 | 9 | $0 (2023) |
| PFIZER INC. | $73.60 | 4 | $0 (2022) |
| Allergan Inc. | $64.89 | 3 | $0 (2019) |
| Amgen Inc. | $60.00 | 4 | $0 (2021) |
| VYNE Pharmaceuticals Inc. | $42.68 | 1 | $0 (2021) |
| Galderma Laboratories, L.P. | $39.01 | 3 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $36.76 | 3 | $0 (2023) |
| UCB, Inc. | $32.37 | 1 | $0 (2019) |
| Janssen Biotech, Inc. | $30.69 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $47.14 | 3 | Regeneron Healthcare Solutions, Inc. ($19.43) |
| 2022 | $106.41 | 6 | Regeneron Healthcare Solutions, Inc. ($33.65) |
| 2021 | $119.88 | 6 | VYNE Pharmaceuticals Inc. ($42.68) |
| 2020 | $70.84 | 5 | Amgen Inc. ($30.00) |
| 2019 | $242.17 | 12 | STRATA Skin Sciences, Inc. ($126.34) |
| 2018 | $119.78 | 8 | Regeneron Healthcare Solutions, Inc. ($39.70) |
| 2017 | $163.23 | 9 | STRATA Skin Sciences, Inc. ($59.64) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/05/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 04/04/2023 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $12.77 | General |
| Category: Dermatology | ||||||
| 01/25/2023 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Dermatology | ||||||
| 10/31/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/15/2022 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Immunology | ||||||
| 07/28/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/19/2022 | PFIZER INC. | EUCRISA (Drug), CIBINQO, PAXLOVID | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: DERMATOLOGY | ||||||
| 06/29/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.19 | General |
| Category: Dermatology | ||||||
| 05/04/2022 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Dermatology | ||||||
| 11/09/2021 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $12.68 | General |
| Category: DERMATOLOGY | ||||||
| 05/21/2021 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: Immunology | ||||||
| 04/22/2021 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: DERMATOLOGY | ||||||
| 03/12/2021 | VYNE Pharmaceuticals Inc. | AMZEEQ (Drug) | Food and Beverage | In-kind items and services | $42.68 | General |
| Category: Treatment of ACNE Vulgaris | ||||||
| 01/22/2021 | Amgen Inc. | Otezla (Drug) | Education | In-kind items and services | $15.00 | General |
| Category: Inflammation | ||||||
| 01/13/2021 | Amgen Inc. | Otezla (Drug) | Education | In-kind items and services | $15.00 | General |
| Category: Inflammation | ||||||
| 12/11/2020 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: ACNE | ||||||
| 12/11/2020 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: ACNE | ||||||
| 10/21/2020 | Amgen Inc. | Otezla (Drug) | Education | In-kind items and services | $15.00 | General |
| Category: Inflammation | ||||||
| 09/10/2020 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: Immunology | ||||||
| 04/06/2020 | Amgen Inc. | Otezla (Drug) | Education | In-kind items and services | $15.00 | General |
| Category: Inflammation | ||||||
| 11/20/2019 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/05/2019 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/23/2019 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $2.69 | General |
| Category: Dermatology | ||||||
| 09/17/2019 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $32.37 | General |
| Category: Immunology | ||||||
| 09/10/2019 | STRATA Skin Sciences, Inc. | XTRAC (Device) | Food and Beverage | In-kind items and services | $2.09 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 624 | 1,050 | $253,689 | $38,630 |
| 2022 | 16 | 1,795 | 4,316 | $721,795 | $184,461 |
| 2021 | 21 | 2,516 | 5,888 | $901,613 | $292,580 |
| 2020 | 23 | 2,994 | 6,996 | $1.1M | $320,715 |
Total Patients
7,929
Total Services
18,250
Medicare Billing
$836,385
Procedure Codes
70
All Medicare Procedures & Services
70 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 21 | 26 | $61,925 | $10,454 | 16.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 96 | 103 | $45,334 | $6,043 | 13.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 155 | 161 | $37,938 | $4,808 | 12.7% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 11 | 14 | $20,266 | $4,564 | 22.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 108 | 109 | $33,999 | $4,379 | 12.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 61 | 63 | $25,454 | $3,819 | 15.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 122 | 522 | $12,504 | $2,080 | 16.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 22 | 22 | $7,924 | $1,125 | 14.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $5,004 | $697.85 | 13.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 17 | $3,341 | $660.30 | 19.8% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 79 | 87 | $152,846 | $38,126 | 24.9% |
| 96910 | Therapy procedure using ultraviolet radiation with tar or petroleum jelly application | Office | 2022 | 13 | 271 | $54,734 | $25,698 | 47.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 363 | 438 | $87,741 | $22,524 | 25.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 430 | 594 | $117,868 | $22,305 | 18.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 186 | 216 | $76,111 | $18,154 | 23.9% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2022 | 40 | 51 | $54,638 | $16,773 | 30.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 382 | 2,290 | $40,865 | $10,117 | 24.8% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2022 | 31 | 32 | $42,116 | $5,960 | 14.2% |
| J7308 | Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) | Office | 2022 | 14 | 19 | $8,265 | $4,722 | 57.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 58 | 64 | $16,635 | $4,543 | 27.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 25 | 32 | $16,361 | $4,208 | 25.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 82 | 122 | $24,288 | $3,432 | 14.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 33 | 35 | $11,698 | $2,789 | 23.8% |
| 10040 | Acne surgery | Office | 2022 | 30 | 32 | $9,761 | $2,577 | 26.4% |
| 96567 | Application of light to destroy precancer skin growth | Office | 2022 | 14 | 17 | $5,287 | $1,914 | 36.2% |
About Dr. Michael Ebertz, M.D
Dr. Michael Ebertz, M.D is a MOHS-Micrographic Surgery healthcare provider based in Burnsville, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144386392.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Ebertz, M.D has received a total of $869.45 in payments from pharmaceutical and medical device companies, with $47.14 received in 2023. These payments were reported across 49 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($774.50).
As a Medicare-enrolled provider, Ebertz has provided services to 7,929 Medicare beneficiaries, totaling 18,250 services with total Medicare billing of $836,385. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.
Ad
Practice Information
- Specialty MOHS-Micrographic Surgery
- Other Specialties Dermatology
- Location Burnsville, MN
- Active Since 12/29/2006
- Last Updated 10/15/2020
- Taxonomy Code 207ND0101X
- Entity Type Individual
- NPI Number 1144386392
Products in Payments
- XTRAC (Device) $217.10
- DUPIXENT (Biological) $108.69
- EUCRISA (Drug) $73.60
- Otezla (Drug) $73.16
- DUPIXENT DUPILUMAB INJECTION (Biological) $56.17
- AMZEEQ (Drug) $42.68
- KYBELLA (Biological) $41.24
- TREMFYA (Drug) $35.38
- Cimzia (Drug) $32.37
- AKLIEF (Drug) $28.69
- COSENTYX (Biological) $21.82
- OPZELURA (Drug) $21.19
- REMICADE (Biological) $18.54
- VALCHLOR (Drug) $15.42
- COSENTYX (Drug) $14.94
- ENSTILAR (Drug) $13.51
- BOTOX COSMETIC (Biological) $12.43
- Sernivo Spray (Drug) $11.66
- RHOFADE (Drug) $11.22
- EPIDUO FORTE (Drug) $10.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.